Free Trial

Healthpeak Properties, Inc. (NYSE:DOC) Plans $0.10 Monthly Dividend

Healthpeak Properties logo with Finance background
Remove Ads

Healthpeak Properties, Inc. (NYSE:DOC - Get Free Report) declared a monthly dividend on Wednesday, April 9th, Wall Street Journal reports. Investors of record on Monday, June 16th will be paid a dividend of 0.1017 per share by the real estate investment trust on Friday, June 27th. This represents a $1.22 dividend on an annualized basis and a yield of 6.57%. The ex-dividend date is Monday, June 16th.

Healthpeak Properties has raised its dividend by an average of 34.0% annually over the last three years. Healthpeak Properties has a payout ratio of 420.7% indicating that the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Equities analysts expect Healthpeak Properties to earn $1.95 per share next year, which means the company should continue to be able to cover its $1.22 annual dividend with an expected future payout ratio of 62.6%.

Healthpeak Properties Stock Performance

Shares of DOC traded up $0.42 during midday trading on Monday, hitting $18.58. 1,703,750 shares of the stock traded hands, compared to its average volume of 4,889,231. The business's 50 day moving average price is $19.79 and its two-hundred day moving average price is $20.81. The firm has a market capitalization of $13.00 billion, a PE ratio of 53.09, a price-to-earnings-growth ratio of 2.17 and a beta of 1.02. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.35 and a current ratio of 1.35. Healthpeak Properties has a 1-year low of $17.33 and a 1-year high of $23.26.

Remove Ads

Wall Street Analyst Weigh In

DOC has been the subject of a number of analyst reports. Morgan Stanley raised shares of Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 target price for the company in a research note on Wednesday, January 15th. Robert W. Baird reduced their price objective on Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a research report on Tuesday, February 11th. Wedbush restated an "outperform" rating and issued a $24.00 target price on shares of Healthpeak Properties in a research report on Friday. StockNews.com upgraded Healthpeak Properties from a "sell" rating to a "hold" rating in a research report on Saturday, March 22nd. Finally, Scotiabank lowered their price target on Healthpeak Properties from $24.00 to $23.00 and set a "sector outperform" rating on the stock in a report on Friday, February 28th. Four analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Healthpeak Properties currently has a consensus rating of "Moderate Buy" and a consensus price target of $23.83.

Check Out Our Latest Stock Analysis on DOC

About Healthpeak Properties

(Get Free Report)

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

Featured Articles

Dividend History for Healthpeak Properties (NYSE:DOC)

Should You Invest $1,000 in Healthpeak Properties Right Now?

Before you consider Healthpeak Properties, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.

While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

5 Stocks to BUY Now as Tariff Uncertainty Fades

5 Stocks to BUY Now as Tariff Uncertainty Fades

These 5 Stocks have been beaten down by tariffs, but now that the uncertainty is fading, they're set for a rebound with all the potential downside already priced in.

Related Videos

5 Stocks to BUY Now as Tariff Uncertainty Fades

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads